Animal Microbiome Market Latest Trends and Growth Factors Analysis 2024 to 2031

Animal Microbiome Market worth $12.4 Billion by 2030 - Exclusive Report by InsightAce Analytic

InsightAce Analytic Pvt. Ltd.'s recently published report, "Global Animal Microbiome Market- By Trends, Industry Competition Analysis, Revenue (US$ Millions) and Forecast Till 2030," provides an in-depth analysis and comprehensive study of the market, examining its key factors.

Get Free Access to Demo Report, Excel Pivot and ToC: www.insightaceanalytic.com/request-sample/1046

According to the most recent market intelligence research report by InsightAce Analytic, the global Animal Microbiome market was valued at US$ 5.75 billion in 2021 and is expected to reach US$ 12.4 billion in 2030, with a promising CAGR of 9.0% from 2022 to 2030.

In recent years, the sustainability of animal production has received a lot of attention. The microbiome has emerged as a valuable target for goods designed to increase animal production sustainability while also increasing productivity. Animal microbiome research is centered on the study of microbial populations that inhabit animals, with the goal of determining their role in health, sickness, and development. The animal microbiome is essential for gastrointestinal health, immune function, and digestion. In poultry, the gastrointestinal tract comprises 70% of immune cells, highlighting the gut's relevance for overall health. In addition to animal health, the gut microbiome influences production and microbiological safety.

The rising need to identify, treat, and eliminate diseases in livestock and companion animals, as well as the growing pet population, have all contributed to market expansion. The market is quickly expanding as a result of increased pet ownership and livestock population growth over the last year. Dietary supplements that enhance immune health have been increasingly popular in recent years. Increased pet spending, which results in a demand for safe and healthful foods to keep pets healthy, is predicted to increase the need for the animal microbiome. Increased emphasis on animal health innovation has resulted in some promising industry growth opportunities. The market expansion is also attributed to technology advancements in the animal microbiome, such as the introduction of microbiome DNA sequencing, which includes cutting-edge bioinformatic analysis. Increased demand for meat and meat products, increased worry about antibiotic resistance to enhance gut health, and the growing relevance of protein-rich diets are all expected to drive market expansion throughout the forecast period.

Expert Knowledge, just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-03

The Association for Pet Obesity Prevention reported that 56% of dogs and 60% of cats were overweight or obese in 2018. Extra weight in pets can lead to high blood pressure, difficulties breathing, arthritis, joint health issues, and a compromised immune system. Key firms concentrate on product development, such as early detection and predictive microbiome-based modes, in order to give more effective techniques for treating chronic diseases in animals. For example, in May 2021, Gnubiotics Sciences SA reported that the European Patent Office had granted it a patent on microbiome markers for diagnosing, predicting, and treating pet obesity. This is the first study to address a microbiome-based approach for predicting, diagnosing, and treating feline obesity, which is a major cause of diabetes and chronic kidney disease (CKD) in felines.

The prominent players in the Animal Microbiome industry include:
Adisseo France SAS, Animal Biome, Inc, ANIZOME LLC, Arm & Hammer Animal Nutrition, Cargill, Chr. Hansen Holding A/S, Cytophage Technologies Inc., DuPont Industrial Biosciences, Elanco Animal Health, Eligo Bioscience, EnBiotix, Inc., FermBiotics, FOLIUM Science, Gnubiotics Sciences SA, Hill's Pet Nutrition, Inc., Intralytix, ISOThrive , Jefo Nutrition Inc., Koninklijke DSM N.V. (Royal DSM), Lallemand Inc., Land O'Lakes, Inc., Leiber GmbH, Microbiome Insights, Inc., MicroSintesis, Native Microbials, NomNomNow Inc., Novozymes A/S, Novus International Inc., Ocean Harvest Technology, Orion Pharma Animal Health, Phage Technologies SA, Phagelux, Inc., Phibro Animal Health Corporation, Phytobiotics Futterzusatzstoffe GmbH, Primal Health, LLC, ProDigest, Proteon Pharmaceuticals, Pure Cultures, Purina Animal Nutrition, Resilient Biotics, Tonisity International Limited, Vetanco, VetoPhage, and List of Other prominent players.

Key Industry Developments from Leading Players:
• In Jan 2022, Felix Biotechnology announced a partnership with AnimalBiome to develop new solutions to address diarrhea in pets. Felix has several ongoing partnerships to develop phage-based solutions with personal care and cosmetic companies, and through this partnership, the company plans to expand its footprint into animal health.
• In Aug 2021, Chr. Hansen introduced a new product portfolio of stable live probiotics for use in pet foods and supplements, including Chr. Hansen Pet-Prostart, Chr. Hansen Pet-Proessentials and Chr. Hansen Pet-Provital. Followed to this, the company has introduced Bovacillus, a new solution to support dairy and beef cattle health and performance. Through these product launches, Chr. Hansen focuses on supporting healthy digestion, immunity, and overall wellbeing of animals.
• In Aug 2021, ISOThrive Inc. received a Composition of Matter and Production Method patent for its first FarmaceuticalTM Maltosyl-Isomaltooligosaccharides (MIMO), a prebiotic for use as an animal feed additive and pet food supplement. Through this patent, the company has created emerging opportunities in pet health with supplements that support better digestion with less reliance on medications.
• In July 2021, Cargill invested in AnimalBiome to boost the introduction of new products and insights in the pet microbiome modulation space. Through this partnership with Cargill, AnimalBiome advances a clear leadership position in an exciting, growing market and creates novel products to restore balance to the gut microbiomes of companion animals.
• In Nov 2019, GNUbiotics Sciences announced a strategic agreement with Evonik Nutrition & Care to manufacture GNUbiotics' Animal Milk Oligosaccharide, AMObiomeTM. First-in-class Animal Milk Oligosaccharide AMObiomeTM to respond to the increasing demand for natural break-through products for companion and production animal health

Animal Microbiome Market Regional Analysis:
Asia and Europe accounted for the biggest revenue share in 2021, and are expected to grow at the quickest CAGR from 2022 through 2030. Improved research and development activities, technological improvements, and an increasing number of pet owners are driving the regional animal microbiome market growth. The Asia Pacific region is also expected to provide substantial growth potential throughout the forecast period due to expanding animal health awareness, an increasing pet population, and a growing number of government efforts to promote animal health.

Unlock Your GTM Strategy: www.insightaceanalytic.com/customisation/1046

Animal Microbiome Market Segments
Animal Microbiome Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2019 to 2030 based on Product
• Phage Therapy Product
• Functional Food
o Probiotics
o Prebiotics
o Others
• Sequencing Platforms
• Feed Additives/Functional Ingredients
• Alternative Proteins and Alternative Feed
• Other Innovative Microbiome Products and Therapies

Animal Microbiome Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2019 to 2030 based on Application
• Disease Therapeutics
• Diagnostics
• Nutrition

Animal Microbiome Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2019 to 2030 based on Animal Type
• Poultry
• Ruminants
• Swine
• Aquaculture
• Pets

Animal Microbiome Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2019 to 2030 based on Region
• Europe
• North America
• Latin America
• Asia Pacific
• Middle East & Africa
North America Animal Microbiome Market Estimates Revenue (US$ Million) by Country, 2019 to 2030
• U.S.
• Canada
Europe Animal Microbiome Market Estimates Revenue (US$ Million) by Country, 2019 to 2030
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Animal Microbiome Market Estimates Revenue (US$ Million) by Country, 2019 to 2030
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Animal Microbiome Market Estimates Revenue (US$ Million) by Country, 2019 to 2030
• Brazil
• Mexico
• Rest of Latin America

The Middle East & Africa Animal Microbiome Market Estimates Revenue (US$ Million) by Country, 2019 to 2030
• GCC Countries
• South Africa
• Rest of the Middle East & Africa

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.